A study on Siddha Drug (Thetran Vidhai Kudineer) for Type -2 Diabetes Mellitus

Clinical Evaluation of Thetran Vidhai Kudineer In Neerizhivu (Diabetes Mellitus Type-2)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/02/007797

Enrollment

Registered

2017-02-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Type 2 Diabetes Mellitus Health Condition 2: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Thetran Vidhai Kudineer : Thetran Vidhai Kudineer 60ml orally administered two times before food. Duration: 90 Days. (Thetran vidhai (kottai) kudineer which comprises of Thetran vidha

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 30 years to 60 years 2. Known or newly diagnosed( Fasting plasma glucose- (126 mg/dl[7mmol/L] or higher plasma glucose 2 hrs after-(>=200mg/dl[11.1mmol/l]) Glycated haemoglobin( A1C >= 6.5% and 3. Patients who are not taking any other Anti-diabetic drugs.

Exclusion criteria

Exclusion criteria: 1. Age below 30 years to 60 years 2. Glycated hemoglobin above 10.0% 3. Patients with CVS/Hepatic failure/Renal failure 4. Lactating mother 5. Pregnant or planning to become pregnant within the next 6 months. 6. Taking oral anti-diabetic therapies 7. Patients who are on long term use of steroids.

Design outcomes

Primary

Measure	Time frame
The primary outcome measures are Blood sugar and glycosylated hemoglobin (HbA1c). Timepoint: Baseline, 90 days	—

Secondary

Measure	Time frame
Explanatory outcome measures include blood pressure, lipid profile,Body weight, waist circumference. Timepoint: Baseline, 90 days;Secondary outcome measures are self rated quality of life and diabetes symptoms. Timepoint: Baseline,90 days	—

Countries

India

Contacts

Public ContactP Elankani

pitchiahkumar@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026